Natalizumab treatment in paediatric multiple sclerosis: a case of induction, de-escalation and escalation.
Putzki
Norman
N
Stich
Oliver
O
Gartzen
Kristina
K
Kastrup
Oliver
O
Tettenborn
Barbara
B
Rauer
Sebastian
S
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D039441:Integrin alpha4 / Q000276:immunology*; D009103:Multiple Sclerosis / Q000188:drug therapy*; D000069442:Natalizumab; D012720:Severity of Illness Index
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069442:Natalizumab; D039441:Integrin alpha4